Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

Publication date: Available online 8 September 2020Source: The Lancet Respiratory MedicineAuthor(s): Liam G Heaney, John Busby, Catherine E Hanratty, Ratko Djukanovic, Ashley Woodcock, Samantha M Walker, Timothy C Hardman, Joseph R Arron, David F Choy, Peter Bradding, Christopher E Brightling, Rekha Chaudhuri, Douglas C Cowan, Adel H Mansur, Stephen J Fowler, Robert M Niven, Peter H Howarth, James L Lordan, Andrew Menzies-Gow, Tim W Harrison
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research